Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoffer Hother

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 30, 2014
Differential expression of miR-155 and miR-21 in tumor and stroma cells in diffuse large B-cell lymphomaHelga D Munch-Petersen, Ulrik Ralfkiaer, Lene D Sjö, et al.
Plos One|February 19, 2015
Development and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCLSteen Knudsen, Christoffer Hother, Kirsten Grønbæk, et al.
Molecular Cancer|March 23, 2011
miR-449 inhibits cell proliferation and is down-regulated in gastric cancerTony Bou Kheir, Ewa Futoma-Kazmierczak, Anders Jacobsen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 12, 2008
Frequent hypermethylation of DBC1 in malignant lymphoproliferative neoplasmsKirsten Grønbaek, Ulrik Ralfkiaer, Christina Dahl, et al.
Haematologica|July 9, 2013
Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphomaFazila Asmar, Vasu Punj, Jesper Christensen, et al.
Oncotarget|April 12, 2014
Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another "double hit" lymphoma with very poor outcome?Fazila Asmar, Christoffer Hother, Gorjan Kulosman, et al.
Blood|November 8, 2011
Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AMLMarianne Bach Treppendahl, Xiangning Qiu, Alexandra Søgaard, et al.
Scientific Reports|June 17, 2020
The value of circulating microRNAs for early diagnosis of B-cell lymphoma: A case-control study on historical samplesSteffen Jørgensen, Isabella Worlewenut Paulsen, Jakob Werner Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue BiopsiesDavid W Scott, Anja Mottok, Daisuke Ennishi, et al.
Blood|March 30, 2017
Genetic profiling of <i>MYC</i> and <i>BCL2</i> in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impactDaisuke Ennishi, Anja Mottok, Susana Ben-Neriah, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 30, 2014
Differential expression of miR-155 and miR-21 in tumor and stroma cells in diffuse large B-cell lymphomaHelga D Munch-Petersen, Ulrik Ralfkiaer, Lene D Sjö, et al.
Plos One|February 19, 2015
Development and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCLSteen Knudsen, Christoffer Hother, Kirsten Grønbæk, et al.
Molecular Cancer|March 23, 2011
miR-449 inhibits cell proliferation and is down-regulated in gastric cancerTony Bou Kheir, Ewa Futoma-Kazmierczak, Anders Jacobsen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 12, 2008
Frequent hypermethylation of DBC1 in malignant lymphoproliferative neoplasmsKirsten Grønbaek, Ulrik Ralfkiaer, Christina Dahl, et al.
Haematologica|July 9, 2013
Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphomaFazila Asmar, Vasu Punj, Jesper Christensen, et al.
Oncotarget|April 12, 2014
Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another "double hit" lymphoma with very poor outcome?Fazila Asmar, Christoffer Hother, Gorjan Kulosman, et al.
Blood|November 8, 2011
Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AMLMarianne Bach Treppendahl, Xiangning Qiu, Alexandra Søgaard, et al.
Scientific Reports|June 17, 2020
The value of circulating microRNAs for early diagnosis of B-cell lymphoma: A case-control study on historical samplesSteffen Jørgensen, Isabella Worlewenut Paulsen, Jakob Werner Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue BiopsiesDavid W Scott, Anja Mottok, Daisuke Ennishi, et al.
Blood|March 30, 2017
Genetic profiling of <i>MYC</i> and <i>BCL2</i> in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impactDaisuke Ennishi, Anja Mottok, Susana Ben-Neriah, et al.
Pageof 3